Publications by authors named "J M Classe"

Claim this Profile
H
How can we optimize the surgical management of the axilla in breast cancer since the MonarchE trial?
Clémentine Jankowski, Gilles Houvenaeghel, Celine Renaudeau, Jean Leveque, Frederic Marchal, Jean-Marc Classe

Breast Cancer Res Treat· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-intrinsic chemosensitivity assessed by KELIM and prognosis by BRCA status in patients with advanced ovarian carcinomas.
Ondine Becker, Alice Durand, Marion Chevrier, Laetitia Collet, Laurence Gladieff, Jean-Marc Classe

Int J Gynecol Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial.
Jean-Marc Classe, Pierre Meeus, Delphine Hudry, Romuald Wernert, François Quenet

Lancet Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eligibility for Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in Endocrine Receptor-Positive and HER2-Negative Early Breast Cancer by Age and Type of Surgery.
Gilles Houvenaeghel, Jean-Marc Classe, Marie-Pierre Chauvet, Pierre-Emmanuel Colombo, Eva Jouve

Cancers (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omission of Completion Axillary Lymph Node Dissection for Patients with Breast Cancer Treated by Upfront Mastectomy and Sentinel Node Isolated Tumor Cells or Micrometastases.
Gilles Houvenaeghel, Mellie Heinemann, Jean-Marc Classe, Catherine Bouteille, Pierre Gimbergues

Cancers (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis